This research report provides a comprehensive analysis of the PCR and NGS-Based Molecular Diagnostics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global PCR and NGS-Based Molecular Diagnostics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of PCR and NGS-Based Molecular Diagnostics, challenges faced by the industry, and potential opportunities for market players.
The global PCR and NGS-Based Molecular Diagnostics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The PCR and NGS-Based Molecular Diagnostics market presents opportunities for various stakeholders, including Hospitals, Academics/Research Institutions. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in PCR and NGS-Based Molecular Diagnostics market. Additionally, the growing consumer demand present avenues for market expansion.
The global PCR and NGS-Based Molecular Diagnostics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the PCR and NGS-Based Molecular Diagnostics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the PCR and NGS-Based Molecular Diagnostics market.
Market Overview: The report provides a comprehensive overview of the PCR and NGS-Based Molecular Diagnostics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Biomarker Discovery, Blood Sample Testig), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the PCR and NGS-Based Molecular Diagnostics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the PCR and NGS-Based Molecular Diagnostics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the PCR and NGS-Based Molecular Diagnostics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the PCR and NGS-Based Molecular Diagnostics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the PCR and NGS-Based Molecular Diagnostics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the PCR and NGS-Based Molecular Diagnostics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for PCR and NGS-Based Molecular Diagnostics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the PCR and NGS-Based Molecular Diagnostics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- PCR and NGS-Based Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Biomarker Discovery
- Blood Sample Testig
- Others
Market segment by Application
- Hospitals
- Academics/Research Institutions
- Others
Global PCR and NGS-Based Molecular Diagnostics Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Thermofisher
- Illumine
- Paragon Genomics
- Roche
- Qiagen
- Bioo Scientific
- Agilent
- Pillar Biosciences
- LC-Bio Technologies (Hangzhou) CO. LTD.
- iGen Technologies
- Burning Rock
Outline of Major Chapters:
Chapter 1: Introduces the definition of PCR and NGS-Based Molecular Diagnostics, market overview.
Chapter 2: Global PCR and NGS-Based Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of PCR and NGS-Based Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PCR and NGS-Based Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 PCR and NGS-Based Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PCR and NGS-Based Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PCR and NGS-Based Molecular Diagnostics Overall Market Size
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size: 2023 VS 2030
2.2 Global PCR and NGS-Based Molecular Diagnostics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PCR and NGS-Based Molecular Diagnostics Players in Global Market
3.2 Top Global PCR and NGS-Based Molecular Diagnostics Companies Ranked by Revenue
3.3 Global PCR and NGS-Based Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 PCR and NGS-Based Molecular Diagnostics Companies in Global Market, by Revenue in 2023
3.5 Global Companies PCR and NGS-Based Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 PCR and NGS-Based Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 PCR and NGS-Based Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 PCR and NGS-Based Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global PCR and NGS-Based Molecular Diagnostics Market Size Markets, 2023 & 2030
4.1.2 Biomarker Discovery
4.1.3 Blood Sample Testig
4.1.4 Others
4.2 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2024
4.2.2 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2025-2030
4.2.3 By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PCR and NGS-Based Molecular Diagnostics Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Academics/Research Institutions
5.1.4 Others
5.2 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2024
5.2.2 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2025-2030
5.2.3 By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global PCR and NGS-Based Molecular Diagnostics Market Size, 2023 & 2030
6.2 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2024
6.2.2 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue, 2025-2030
6.2.3 By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2030
6.3.2 US PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.3.3 Canada PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.3.4 Mexico PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2030
6.4.2 Germany PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4.3 France PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4.4 U.K. PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4.5 Italy PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4.6 Russia PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4.7 Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.4.8 Benelux PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2030
6.5.2 China PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.5.3 Japan PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.5.4 South Korea PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.5.5 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.5.6 India PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2030
6.6.2 Brazil PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.6.3 Argentina PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2030
6.7.2 Turkey PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.7.3 Israel PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.7.4 Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
6.7.5 UAE PCR and NGS-Based Molecular Diagnostics Market Size, 2019-2030
7 PCR and NGS-Based Molecular Diagnostics Companies Profiles
7.1 Thermofisher
7.1.1 Thermofisher Company Summary
7.1.2 Thermofisher Business Overview
7.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.1.4 Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.1.5 Thermofisher Key News & Latest Developments
7.2 Illumine
7.2.1 Illumine Company Summary
7.2.2 Illumine Business Overview
7.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.2.4 Illumine PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.2.5 Illumine Key News & Latest Developments
7.3 Paragon Genomics
7.3.1 Paragon Genomics Company Summary
7.3.2 Paragon Genomics Business Overview
7.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.3.4 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.3.5 Paragon Genomics Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.4.4 Roche PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.4.5 Roche Key News & Latest Developments
7.5 Qiagen
7.5.1 Qiagen Company Summary
7.5.2 Qiagen Business Overview
7.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.5.4 Qiagen PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.5.5 Qiagen Key News & Latest Developments
7.6 Bioo Scientific
7.6.1 Bioo Scientific Company Summary
7.6.2 Bioo Scientific Business Overview
7.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.6.4 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.6.5 Bioo Scientific Key News & Latest Developments
7.7 Agilent
7.7.1 Agilent Company Summary
7.7.2 Agilent Business Overview
7.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.7.4 Agilent PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.7.5 Agilent Key News & Latest Developments
7.8 Pillar Biosciences
7.8.1 Pillar Biosciences Company Summary
7.8.2 Pillar Biosciences Business Overview
7.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.8.4 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.8.5 Pillar Biosciences Key News & Latest Developments
7.9 LC-Bio Technologies (Hangzhou) CO. LTD.
7.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Summary
7.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
7.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Key News & Latest Developments
7.10 iGen Technologies
7.10.1 iGen Technologies Company Summary
7.10.2 iGen Technologies Business Overview
7.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.10.4 iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.10.5 iGen Technologies Key News & Latest Developments
7.11 Burning Rock
7.11.1 Burning Rock Company Summary
7.11.2 Burning Rock Business Overview
7.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Major Product Offerings
7.11.4 Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue in Global Market (2019-2024)
7.11.5 Burning Rock Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. PCR and NGS-Based Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. PCR and NGS-Based Molecular Diagnostics Market Drivers in Global Market
Table 3. PCR and NGS-Based Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of PCR and NGS-Based Molecular Diagnostics in Global Market
Table 5. Top PCR and NGS-Based Molecular Diagnostics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global PCR and NGS-Based Molecular Diagnostics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global PCR and NGS-Based Molecular Diagnostics Revenue Share by Companies, 2019-2024
Table 8. Global Companies PCR and NGS-Based Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 PCR and NGS-Based Molecular Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PCR and NGS-Based Molecular Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - PCR and NGS-Based Molecular Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2025-2030
Table 30. Thermofisher Company Summary
Table 31. Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 32. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 33. Thermofisher Key News & Latest Developments
Table 34. Illumine Company Summary
Table 35. Illumine PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 36. Illumine PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 37. Illumine Key News & Latest Developments
Table 38. Paragon Genomics Company Summary
Table 39. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 40. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 41. Paragon Genomics Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 44. Roche PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 45. Roche Key News & Latest Developments
Table 46. Qiagen Company Summary
Table 47. Qiagen PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 48. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 49. Qiagen Key News & Latest Developments
Table 50. Bioo Scientific Company Summary
Table 51. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 52. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 53. Bioo Scientific Key News & Latest Developments
Table 54. Agilent Company Summary
Table 55. Agilent PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 56. Agilent PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 57. Agilent Key News & Latest Developments
Table 58. Pillar Biosciences Company Summary
Table 59. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 60. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 61. Pillar Biosciences Key News & Latest Developments
Table 62. LC-Bio Technologies (Hangzhou) CO. LTD. Company Summary
Table 63. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 64. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 65. LC-Bio Technologies (Hangzhou) CO. LTD. Key News & Latest Developments
Table 66. iGen Technologies Company Summary
Table 67. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 68. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 69. iGen Technologies Key News & Latest Developments
Table 70. Burning Rock Company Summary
Table 71. Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offerings
Table 72. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 73. Burning Rock Key News & Latest Developments
List of Figures
Figure 1. PCR and NGS-Based Molecular Diagnostics Segment by Type in 2023
Figure 2. PCR and NGS-Based Molecular Diagnostics Segment by Application in 2023
Figure 3. Global PCR and NGS-Based Molecular Diagnostics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global PCR and NGS-Based Molecular Diagnostics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2023
Figure 8. By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 9. By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 10. By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 12. By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 14. By Region - Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 15. By Country - North America PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 16. US PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 20. Germany PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 21. France PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 28. China PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 32. India PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 34. Brazil PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa PCR and NGS-Based Molecular Diagnostics Revenue Market Share, 2019-2030
Figure 37. Turkey PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE PCR and NGS-Based Molecular Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 41. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Illumine PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Roche PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Agilent PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
